Back

drs. A.B.B. (Joke) de Voert

drs. A.B.B. (Joke) de Voert

Full Professor

Show full profile

Research Output (128)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

Foeldvari Ivan, Klotsche Jens, Simonini Gabriele, Edelsten Clive, Angeles-Han Sheila T., Bangsgaard Regitze, de Boer Joke, Brumm Gabriele, Torrent Rosa Bou, Constantin Tamas, DeLibero Cinzia, Diaz Jesus, Gerloni Valeria Maria, Guedes Margarida, Heiligenhaus Arnd, Kotaniemi Kaisu, Leinonen Sanna, Minden Kirsten, Miranda Vasco, Miserocchi Elisabetta, Nielsen Susan, Niewerth Martina, Pontikaki Irene, de Vicuna Carmen Garcia, Zilhao Carla, Yeh Steven, Anton Jordi, Calzada Joan 1 Oct 2019, In: Pediatric rheumatology online journal. 17 14 p.

Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis

Lans A., Van Luijk C. M., Bakker D. S., Ariens L. F. M., Thijs J. L., Van der Schaft J., De Boer J. H., Knol E. F., De Bruin-Weller M. S., Balak D. M. W. Aug 2019, In: Allergy. 74 , p. 714-714

Prolonged cone b-wave on electroretinography is associated with more severe inflammation in non-infectious uveitis

Brouwer Anna, van Genderen Maria M., de Wit Gerard, ten Dam Ninette, Wijnhoven Ralph, de Boer Joke Jul 2019, In: Investigative ophthalmology & visual science. 60

Predicting uveitis in juvenile idiopathic arthritis:from biomarkers to clinical practice

Haasnoot Anne-Mieke J. W., Kuiper Jonas J. W., de Boer Joke H. 3 Jun 2019, In: Expert Review of Clinical Immunology. 15 , p. 657-666 10 p.

Uveitis as an immune-related toxicity during checkpoint inhibitor immunotherapy

Ayuso V. Kalinina, Ossewaarde-van Norel J., Kouwenberg C., Suijkerbuijk K. P. M., Kuiper J. J. W., de Boer J. H. Mar 2019, In: Acta Ophthalmologica. 97 , p. 16-16

Blood monocytes distinguish individuals with orbital lymphoma

Laban K. G., Kalmann R., Hiddingh S., Mertens J., Rijken R., Pandit A., Eenhorst C., van der Veen R., de Boer J. H., Radstake T. R. D. J., Kuiper J. J. W. Mar 2019, In: Acta Ophthalmologica. 97 , p. 28-28

CCR6+T cells are an early predictor of the need for systemic immunomodulatory treatment in non-infectious uveitis

Verhagen F. H., Hiddingh S., Rijken R., Pandit A., Leijten E., Nordkamp M. O., ten Dam-van Loon N. H., Nierkens S., Imhof S. M., de Boer J. H., Radstake T. R. D. J., Kuiper J. J. W. Mar 2019, In: Acta Ophthalmologica. 97 , p. 18-18

Tocilizumab as an effective treatment in children with refractory intermediate and panuveitis

Wennink R. A. W., Ayuso V. Kalinina, de Vries L., Vastert S. J., de Boer J. H. Mar 2019, In: Acta Ophthalmologica. 97 , p. 16-16

The effectiveness of immunosuppressive therapy in patients with central multifocal choroiditis: a retrospective cohort study

de Groot E. L., Ossewaarde-van Norel J., de Boer J. H., ten Dam-van Loon N. H. Mar 2019, In: Acta Ophthalmologica. 97 , p. 16-16

Risk factors for glaucoma surgery secondary to childhood uveitis

van Meerwijk C. L. L. I., Wieringa W. G., de Boer J. H., Jansonius N. M., Los L. I. Mar 2019, In: Acta Ophthalmologica. 97 , p. 17-17

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not